spacer
home > pmps > spring 2019 > digitising the chain
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Digitising the Chain

The pharmaceutical and medical supplies sector, like every other, has changed almost beyond recognition in the past decade, thanks to the development and availability of data-driven systems. For example, artificial intelligence is widely seen as the next frontier in R&D, helping to speed up clinical trials, improve their validity, and get drugs to market sooner.

Production, warehousing, and distribution have undergone a similar transition, with automation and data insights increasingly being used to speed up processes and improve traceability and compliance. Digital processes now impact every aspect of the modern supply chain, from Tier 1 drugs manufacturers to smallmedium enterprises supplying sterile packaging or components.

System Selection

Agile systems enable pharma companies to meet the requirements and challenges of a rapidly evolving sector. The availability of real-time data means production managers can make better informed decisions, moving from merely reporting what is happening on the shop floor to driving positive action. Its application is akin to researchers conducting clinical trials using data from multiple sources, such as wearable technology, rather than relying on limited and/or historic results to deliver more rigorous results faster.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Rod Schregardus is a Consultant Manager at pharma software expert, Access Group. Specialising in global new business for Access’ advanced planning and scheduling software, Access Orchestrate, Rod boasts over 20 years in the manufacturing industry and works with pharma companies across the world.
spacer
Rod Schregardus
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sphere Fluidics Closes a $4.8 million USD (£3.7 million) Funding Round

Cambridge, UK, 10 June 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that it has closed an additional tranche of investment of $2.9 million (£2.2 million), securing a total of $4.8 million (£3.7 million) in investment. The funding will be used as working capital for the Company’s Cyto-Mine® Single Cell Analysis System, expansion of the UK facility and enable the doubling of personnel through the opening of a new US Sales Office and Demo Lab in California.
More info >>

White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement